Evgen Pharma PLC
LSE:EVG

Watchlist Manager
Evgen Pharma PLC Logo
Evgen Pharma PLC
LSE:EVG
Watchlist
Price: 0.8 GBX Market Closed
Market Cap: 3.4m GBX

Relative Value

EVG doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of EVG.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EVG Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
4.1
Median 5Y
4.1
Industry
8
Forward
6.7
vs History
vs Industry
Median 3Y
-1
Median 5Y
-3.4
Industry
23.5
Forward
-0
vs History
vs Industry
Median 3Y
-1
Median 5Y
-3.3
Industry
21.9
vs History
vs Industry
Median 3Y
-1
Median 5Y
-3.3
Industry
24.3
vs History
vs Industry
Median 3Y
0.9
Median 5Y
1.8
Industry
3.2
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
8.1
Forward
-0.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
Median 3Y
0.1
Median 5Y
-1.5
Industry
5.9
vs History
vs Industry
Median 3Y
0.1
Median 5Y
-1.5
Industry
6.2
vs History
vs Industry
Median 3Y
0.1
Median 5Y
-2
Industry
7.7
vs History
vs Industry
Median 3Y
0.1
Median 5Y
-2
Industry
6.3
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
15
Industry
5.6

Multiples Across Competitors

EVG Competitors Multiples
Evgen Pharma PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Evgen Pharma PLC
LSE:EVG
3.4m GBP 4.1 -1 0.1 0.1
IL
Can Fite Biopharma Ltd
TASE:CANF
707T ILS 255 921 586.5 -17 575 047.8 -17 246 503.8 -17 208 113.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 865 457.5 -160 957.5 -195 453.7 -193 223.4
US
Abbvie Inc
NYSE:ABBV
391.9B USD 6.6 166.9 16.2 23
US
Amgen Inc
NASDAQ:AMGN
173.8B USD 4.8 24.8 18 18
US
Gilead Sciences Inc
NASDAQ:GILD
149.7B USD 5.1 18.5 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.8B USD 10.1 32.1 23.5 24.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 080.3 -530.8 -578 -562.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.8B USD 5.7 17.9 17.1 19.3
AU
CSL Ltd
ASX:CSL
81.8B AUD 3.5 18.3 12.4 15.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.2B USD 15.9 1 175.1 158.4 192.1
P/S Multiple
Revenue Growth P/S to Growth
UK
Evgen Pharma PLC
LSE:EVG
Average P/S: 26 344 470.9
4.1
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
255 921 586.5
140%
1 828 011.3
FR
Pharnext SCA
OTC:PNEXF
33 865 457.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.8
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.1
10%
1
US
E
Epizyme Inc
F:EPE
2 080.3
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
6%
1
AU
CSL Ltd
ASX:CSL
3.5
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
15.9
46%
0.3
P/E Multiple
Earnings Growth PEG
UK
Evgen Pharma PLC
LSE:EVG
Average P/E: 207.6
Negative Multiple: -1
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -17 575 047.8 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 957.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
166.9
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.5
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32.1
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
10%
1.8
AU
CSL Ltd
ASX:CSL
18.3
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 175.1
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Evgen Pharma PLC
LSE:EVG
Average EV/EBITDA: 32.3
0.1
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -17 246 503.8 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 453.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.2
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
11%
1.6
AU
CSL Ltd
ASX:CSL
12.4
8%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
158.4
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Evgen Pharma PLC
LSE:EVG
Average EV/EBIT: 38.1
0.1
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -17 208 113.6 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 223.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -562.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.3
13%
1.5
AU
CSL Ltd
ASX:CSL
15.5
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
192.1
N/A N/A